Training on the Simbionix GI Mentor Shows Sustainable Superiority Compared to Standard Endoscopic Training

By Simbionix Usa Corporation, PRNE
Tuesday, May 3, 2011

CLEVELAND, Ohio, May 4, 2011 - Simbionix USA Corporation, the world's leading provider of
medical education and simulation training products for medical professionals
and the healthcare industry, is pleased to report on the results of a
controlled randomized trial on the company's GI Mentor, conducted by a team
headed by Arnulf Ferlitsch, MD at the Medical University of Vienna, Austria.

The Simbionix GI Mentor virtual simulator provides endoscopic
hands-on training with haptic sensations for the complete spectrum of
Gastroenterology Procedures. Simulation cases are based on real anatomies and
an actual (modified) scope is utilized to perform the procedure, rendering
real time endoscopic display.

The study set out to evaluate the measure to which training on
the GI Mentor can improve objective performance of beginners in endoscopy.
"Simulation based training in GI Endoscopy has been long established in
professional literature as a quick and efficient training tool", remarked
Arnulf Ferlitsch, MD, from the Medical University of Vienna, principal
investigator for this study. "In our 4 year randomized controlled trial
utilizing Simbionix GI Mentor we have demonstrated that training on the GI
Mentor significantly improves and accelerates the acquisition of technical
skills, as well as reduces the performance time of the procedure in real
patients. Moreover, the unique and very exciting result lies in the
demonstration that the GI Mentor VR training is not only superior to the
standard non-simulation training, in terms of real procedure performance, but
this superiority is long lasting and is still evident after 60 endoscopic
procedures have been performed. Results of such significance are expected to
further drive the adoption of GI simulation as the leading training tool for
endoscopic proficiency acquisition." The article was published in Endoscopy
2010; 42: 1049-1056.

Dr. Yael Friedman, Director of Regulatory Affairs at
Simbionix, commented "This is an important study that Dr. Ferlitsch and his
colleges have published, demonstrating the contribution of the GI Mentor to
improving healthcare outcomes. It is a valuable addition to over 40 published
studies over the last 10 years, validating the GI Mentor as an evidence based
virtual reality training tool for GI Endoscopy. We are very proud of the
study results, as they reflect our ongoing efforts to continuously provide
the most relevant tools to achieve the training objectives set by the medical
community.

The GI Mentor will be exhibited at Simbionix booth #2843 at
DDW 2011, in Chicago Il, May 8-10.

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and
training products for medical professionals and the healthcare industry.
Founded in 1997, the company is committed to delivering high quality
products, advancing clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit
www.simbionix.com

Contact: rebecca@simbionix.com; +1-216-229-2040, ext. 128

.

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :